T 0072/23 (Photostable roxadustat formulation/FIBROGEN) of 23.01.2025
- European Case Law Identifier
- ECLI:EP:BA:2025:T007223.20250123
- Date of decision
- 23 January 2025
- Case number
- T 0072/23
- Petition for review of
- -
- Application number
- 14735770.1
- IPC class
- A61K 9/48A61K 31/472A61K 9/28
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- PHARMACEUTICAL FORMULATIONS OF A HIF HYDROXYLASE INHIBITOR
- Applicant name
- Fibrogen, Inc.
- Opponent name
- Teva Pharmaceutical Industries Ltd.
SANDOZ AG - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56
- Keywords
- Inventive step - (no)
- Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.